共 50 条
- [1] Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial[J]. DIABETOLOGIA, 2022, 65 (07) : 1085 - 1097Waijer, Simke W.论文数: 0 引用数: 0 h-index: 0机构: Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, NetherlandsVart, Priya论文数: 0 引用数: 0 h-index: 0机构: Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, NetherlandsCherney, David Z., I论文数: 0 引用数: 0 h-index: 0机构: Univ Hlth Network, Dept Med, Div Nephrol, Toronto, ON, Canada Univ Toronto, Toronto, ON, Canada Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, NetherlandsChertow, Glenn M.论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Sch Med, Dept Med & Epidemiol, Stanford, CA 94305 USA Stanford Univ, Sch Med, Dept Populat Hlth, Stanford, CA 94305 USA Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, NetherlandsJongs, Niels论文数: 0 引用数: 0 h-index: 0机构: Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, NetherlandsLangkilde, Anna Maria论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, BioPharmaceut R&D, Late Stage Dev Cardiovasc Renal & Metab, Gothenburg, Sweden Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, NetherlandsMann, Johannes F. E.论文数: 0 引用数: 0 h-index: 0机构: KfH Kidney Ctr Munich, Munich, Germany Univ Erlangen Nurnberg, Dept Med 4, Erlangen, Germany Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, NetherlandsMosenzon, Ofri论文数: 0 引用数: 0 h-index: 0机构: Hadassah Hebrew Univ Hosp, Dept Internal Med, Diabet Unit, Jerusalem, Israel Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, NetherlandsMcMurray, John J., V论文数: 0 引用数: 0 h-index: 0机构: Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, NetherlandsRossing, Peter论文数: 0 引用数: 0 h-index: 0机构: Steno Diabet Ctr Copenhagen, Gentofte, Denmark Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, NetherlandsCorrea-Rotter, Ricardo论文数: 0 引用数: 0 h-index: 0机构: Natl Med Sci & Nutr Inst Salvador Zubiran, Mexico City, DF, Mexico Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, NetherlandsStefansson, Bergur, V论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, BioPharmaceut R&D, Late Stage Dev Cardiovasc Renal & Metab, Gothenburg, Sweden Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, NetherlandsToto, Robert D.论文数: 0 引用数: 0 h-index: 0机构: UT Southwestern Med Ctr, Dept Internal Med, Dallas, TX USA Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, NetherlandsWheeler, David C.论文数: 0 引用数: 0 h-index: 0机构: UCL, Dept Renal Med, London, England Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, NetherlandsHeerspink, Hiddo J. L.论文数: 0 引用数: 0 h-index: 0机构: Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands George Inst Global Hlth, Sydney, NSW, Australia Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands
- [2] Efficacy and safety of dapagliflozin on kidney and cardiovascular outcomes by baseline albuminuria: a secondary analysis of the DAPA-CKD trial[J]. DIABETOLOGIA, 2021, 64 (SUPPL 1) : 30 - 30Heerspink, H. J. Lambers论文数: 0 引用数: 0 h-index: 0机构: Univ Med Ctr Groningen, Groningen, Netherlands Univ Med Ctr Groningen, Groningen, NetherlandsWaijer, S. W.论文数: 0 引用数: 0 h-index: 0机构: Univ Med Ctr Groningen, Groningen, Netherlands Univ Med Ctr Groningen, Groningen, NetherlandsVart, P.论文数: 0 引用数: 0 h-index: 0机构: Univ Med Ctr Groningen, Groningen, Netherlands Univ Med Ctr Groningen, Groningen, NetherlandsCherney, D. Z. I.论文数: 0 引用数: 0 h-index: 0机构: Univ Toronto, Toronto, ON, Canada Univ Med Ctr Groningen, Groningen, Netherlands论文数: 引用数: h-index:机构:Langkilde, A. M.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Gothenburg, Sweden Univ Med Ctr Groningen, Groningen, NetherlandsMcMurray, J. J. V.论文数: 0 引用数: 0 h-index: 0机构: Univ Glasgow, Glasgow, Lanark, Scotland Univ Med Ctr Groningen, Groningen, NetherlandsRossing, P.论文数: 0 引用数: 0 h-index: 0机构: Steno Diabet Ctr, Copenhagen, Denmark Univ Med Ctr Groningen, Groningen, NetherlandsCorrea-Rotter, R.论文数: 0 引用数: 0 h-index: 0机构: Natl Med Sci & Nutr Inst Salvador Zubiran, Mexico City, DF, Mexico Univ Med Ctr Groningen, Groningen, NetherlandsStefansson, B. V.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Gothenburg, Sweden Univ Med Ctr Groningen, Groningen, NetherlandsToto, R.论文数: 0 引用数: 0 h-index: 0机构: UCL, Dept Internal Med, London, England Univ Med Ctr Groningen, Groningen, NetherlandsWheeler, D.论文数: 0 引用数: 0 h-index: 0机构: UCL, Dept Renal Med, London, England Univ Med Ctr Groningen, Groningen, Netherlands
- [3] Dapagliflozin Effect on Hospital Admissions in Patients With CKD: A Post Hoc Analysis of the DAPA-CKD Trial[J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 25 - 25Schechter, Meir论文数: 0 引用数: 0 h-index: 0机构: Univ Med Ctr Groningen, Groningen, Netherlands Hadassah Univ, Med Ctr, Jerusalem, Israel Univ Med Ctr Groningen, Groningen, NetherlandsJongs, Niels论文数: 0 引用数: 0 h-index: 0机构: Univ Med Ctr Groningen, Groningen, Netherlands Univ Med Ctr Groningen, Groningen, Netherlands论文数: 引用数: h-index:机构:Mosenzon, Ofri论文数: 0 引用数: 0 h-index: 0机构: Hadassah Univ, Med Ctr, Jerusalem, Israel Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel Univ Med Ctr Groningen, Groningen, Netherlands论文数: 引用数: h-index:机构:Correa-Rotter, Ricardo论文数: 0 引用数: 0 h-index: 0机构: Natl Med Sci & Nutr Inst Salvador Zubiran, Mexico City, DF, Mexico Univ Med Ctr Groningen, Groningen, NetherlandsRossing, Peter论文数: 0 引用数: 0 h-index: 0机构: Steno Diabet Ctr Copenhagen, Herlev, Denmark Univ Med Ctr Groningen, Groningen, NetherlandsLangkilde, Anna Maria论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, BioPharmaceut R&D, Gothenburg, Sweden Univ Med Ctr Groningen, Groningen, NetherlandsSjostrom, David论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, BioPharmaceut R&D, Gothenburg, Sweden Univ Med Ctr Groningen, Groningen, NetherlandsToto, Robert D.论文数: 0 引用数: 0 h-index: 0机构: UT Southwestern Med Ctr, Dept Internal Med, Dallas, TX USA Univ Med Ctr Groningen, Groningen, NetherlandsWheeler, David C.论文数: 0 引用数: 0 h-index: 0机构: UCL, Fac Med Sci, London, England Univ Med Ctr Groningen, Groningen, NetherlandsHeerspink, Hiddo J. L.论文数: 0 引用数: 0 h-index: 0机构: Univ Med Ctr Groningen, Groningen, Netherlands George Inst Global Hlth, Newtown, NSW, Australia Univ Med Ctr Groningen, Groningen, Netherlands
- [4] The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics[J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 (10) : 1700 - 1711Wheeler, David C.论文数: 0 引用数: 0 h-index: 0机构: UCL, Dept Renal Med, London, England UCL, Dept Renal Med, London, EnglandStefansson, Bergur, V论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, BioPharmaceut R&D, Late Stage Dev Cardiovasc Renal & Metab, Gothenburg, Sweden UCL, Dept Renal Med, London, EnglandBatiushin, Mikhail论文数: 0 引用数: 0 h-index: 0机构: Rostov State Med Univ, Dept Nephrol, Rostov Na Donu, Russia UCL, Dept Renal Med, London, EnglandBilchenko, Oleksandr论文数: 0 引用数: 0 h-index: 0机构: Kharkiv Med Acad Postgrad Educ, Kharkiv, Ukraine UCL, Dept Renal Med, London, EnglandCherney, David Z., I论文数: 0 引用数: 0 h-index: 0机构: Univ Hlth Network, Toronto Gen Hosp Res Inst, Toronto, ON, Canada Univ Toronto, Dept Med, Div Nephrol, Toronto, ON, Canada UCL, Dept Renal Med, London, EnglandChertow, Glenn M.论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Dept Epidemiol & Populat Hlth, Sch Med, Stanford, CA USA Stanford Univ, Dept Med, Sch Med, Stanford, CA USA UCL, Dept Renal Med, London, EnglandDouthat, Walter论文数: 0 引用数: 0 h-index: 0机构: Hosp Privado Univ Cordoba, Dept Nephrol, Cordoba, Argentina UCL, Dept Renal Med, London, EnglandDwyer, Jamie P.论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Univ, Med Ctr, Nashville, TN USA UCL, Dept Renal Med, London, EnglandEscudero, Elizabeth论文数: 0 引用数: 0 h-index: 0机构: Cayetano Heredia Univ, Hosp Arzobispo Loayza, Div Nephrol, Lima, Peru UCL, Dept Renal Med, London, EnglandPecoits-Filho, Roberto论文数: 0 引用数: 0 h-index: 0机构: Pontificia Univ Catolica Parana, Sch Med, Curitiba, Parana, Brazil Arbor Res Collaborat Hlth, Ann Arbor, MI USA UCL, Dept Renal Med, London, England论文数: 引用数: h-index:机构:Gorriz, Jose Luis论文数: 0 引用数: 0 h-index: 0机构: Univ Valencia, Univ Clin Hosp, Dept Nephrol, INCLIVA, Valencia, Spain UCL, Dept Renal Med, London, EnglandGreene, Tom论文数: 0 引用数: 0 h-index: 0机构: Univ Utah Hlth Sci, Study Design & Biostat Ctr, Salt Lake City, UT USA UCL, Dept Renal Med, London, EnglandHaller, Hermann论文数: 0 引用数: 0 h-index: 0机构: Hannover Med Sch, Hannover, Germany UCL, Dept Renal Med, London, EnglandHou, Fan Fan论文数: 0 引用数: 0 h-index: 0机构: Southern Med Univ, Natl Clin Res Ctr Kidney Dis, Dept Med, Div Nephrol, Guangzhou, Peoples R China UCL, Dept Renal Med, London, EnglandKang, Shin-Wook论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Dept Internal Med, Div Nephrol, Coll Med, Seoul, South Korea UCL, Dept Renal Med, London, EnglandIsidto, Rey论文数: 0 引用数: 0 h-index: 0机构: Healthlink Med Dent Surg Clin & Diagnost Ctr, Iloilo, Philippines UCL, Dept Renal Med, London, EnglandKhullar, Dinesh论文数: 0 引用数: 0 h-index: 0机构: Max Super Special Hosp, Dept Nephrol & Renal Transplant Med, New Delhi, India UCL, Dept Renal Med, London, EnglandMark, Patrick B.论文数: 0 引用数: 0 h-index: 0机构: Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland UCL, Dept Renal Med, London, EnglandMcMurray, John J., V论文数: 0 引用数: 0 h-index: 0机构: Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland UCL, Dept Renal Med, London, EnglandKashihara, Naoki论文数: 0 引用数: 0 h-index: 0机构: Kawasaki Med Sch, Dept Nephrol & Hypertens, Okayama, Japan UCL, Dept Renal Med, London, EnglandNowicki, Michal论文数: 0 引用数: 0 h-index: 0机构: Med Univ Lodz, Dept Nephrol Hypertens & Kidney Transplantat, Lodz, Poland UCL, Dept Renal Med, London, EnglandPersson, Frederik论文数: 0 引用数: 0 h-index: 0机构: Steno Diabet Ctr Copenhagen, Gentofte, Denmark UCL, Dept Renal Med, London, EnglandCorrea-Rotter, Ricardo论文数: 0 引用数: 0 h-index: 0机构: Natl Med Sci & Nutr Inst Salvador Zubiran, Mexico City, DF, Mexico UCL, Dept Renal Med, London, EnglandRossing, Peter论文数: 0 引用数: 0 h-index: 0机构: Steno Diabet Ctr Copenhagen, Gentofte, Denmark Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark UCL, Dept Renal Med, London, EnglandToto, Robert D.论文数: 0 引用数: 0 h-index: 0机构: UT Southwestern Med Ctr, Dept Internal Med, Dallas, TX USA UCL, Dept Renal Med, London, EnglandUmanath, Kausik论文数: 0 引用数: 0 h-index: 0机构: Henry Ford Hosp, Div Nephrol & Hypertens, Detroit, MI 48202 USA Wayne State Univ, Div Nephrol & Hypertens, Detroit, MI USA UCL, Dept Renal Med, London, EnglandVan Bui, Pham论文数: 0 引用数: 0 h-index: 0机构: Pham Ngoc Thach Med Univ, Ho Chi Minh City, Vietnam UCL, Dept Renal Med, London, EnglandWittmann, Istvan论文数: 0 引用数: 0 h-index: 0机构: Univ Pecs, Dept Med 2, Med Sch, Pecs, Hungary Univ Pecs, Nephrol Diabet Ctr, Med Sch, Pecs, Hungary UCL, Dept Renal Med, London, EnglandLindberg, Magnus论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, BioPharmaceut R&D, Late Stage Dev Cardiovasc Renal & Metab, Gothenburg, Sweden UCL, Dept Renal Med, London, EnglandSjostrom, C. David论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, BioPharmaceut R&D, Late Stage Dev Cardiovasc Renal & Metab, Gothenburg, Sweden UCL, Dept Renal Med, London, EnglandLangkilde, Anna Maria论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, BioPharmaceut R&D, Late Stage Dev Cardiovasc Renal & Metab, Gothenburg, Sweden UCL, Dept Renal Med, London, EnglandHeerspink, Hiddo J. L.论文数: 0 引用数: 0 h-index: 0机构: Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands UCL, Dept Renal Med, London, England
- [5] DAPA-CKD: A Regional Analysis of Kidney and Cardiovascular Outcomes[J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 724 - 724Correa-Rotter, Ricardo论文数: 0 引用数: 0 h-index: 0机构: Natl Med Sci & Nutr Inst Salvador Zubiran, Mexico City, DF, Mexico Natl Med Sci & Nutr Inst Salvador Zubiran, Mexico City, DF, MexicoVart, Priya论文数: 0 引用数: 0 h-index: 0机构: Univ Med Ctr Groningen, Groningen, Netherlands Natl Med Sci & Nutr Inst Salvador Zubiran, Mexico City, DF, MexicoJongs, Niels论文数: 0 引用数: 0 h-index: 0机构: Univ Med Ctr Groningen, Groningen, Netherlands Natl Med Sci & Nutr Inst Salvador Zubiran, Mexico City, DF, MexicoHou, Fan Fan论文数: 0 引用数: 0 h-index: 0机构: Southern Med Univ, Natl Clin Res Ctr Kidney Dis, Guangzhou, Peoples R China Natl Med Sci & Nutr Inst Salvador Zubiran, Mexico City, DF, MexicoChertow, Glenn M.论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Sch Med, Stanford, CA USA Natl Med Sci & Nutr Inst Salvador Zubiran, Mexico City, DF, MexicoLangkilde, Anna Maria论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Gothenburg, Sweden Natl Med Sci & Nutr Inst Salvador Zubiran, Mexico City, DF, Mexico论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:Sjostrom, David论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Gothenburg, Sweden Natl Med Sci & Nutr Inst Salvador Zubiran, Mexico City, DF, MexicoStefansson, Bergur V.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Gothenburg, Sweden Natl Med Sci & Nutr Inst Salvador Zubiran, Mexico City, DF, MexicoToto, Robert D.论文数: 0 引用数: 0 h-index: 0机构: UT SouthWestern Med Ctr, Dallas, TX USA Natl Med Sci & Nutr Inst Salvador Zubiran, Mexico City, DF, MexicoDouthat, Walter论文数: 0 引用数: 0 h-index: 0机构: Hosp Privado Univ Cordoba, Cordoba, Argentina Natl Med Sci & Nutr Inst Salvador Zubiran, Mexico City, DF, MexicoEscudero, Elizabeth T.论文数: 0 引用数: 0 h-index: 0机构: Cayetano Heredia Univ, Hosp Arzobispo Loayza, Lima, Peru Natl Med Sci & Nutr Inst Salvador Zubiran, Mexico City, DF, MexicoIsidto, Rey A.论文数: 0 引用数: 0 h-index: 0机构: Healthlink Med Dent Surg Clin & Diagnost Ctr, Iloilo, Philippines Natl Med Sci & Nutr Inst Salvador Zubiran, Mexico City, DF, MexicoKhullar, Dinesh论文数: 0 引用数: 0 h-index: 0机构: Max Super Special Hosp Saket, New Delhi, India Natl Med Sci & Nutr Inst Salvador Zubiran, Mexico City, DF, MexicoBajaj, Harpreet S.论文数: 0 引用数: 0 h-index: 0机构: LMC Diabet & Endocrinol, Brampton, ON, Canada Natl Med Sci & Nutr Inst Salvador Zubiran, Mexico City, DF, MexicoWheeler, David C.论文数: 0 引用数: 0 h-index: 0机构: UCL, London, England Natl Med Sci & Nutr Inst Salvador Zubiran, Mexico City, DF, MexicoHeerspink, Hiddo J. L.论文数: 0 引用数: 0 h-index: 0机构: Univ Med Ctr Groningen, Groningen, Netherlands George Inst Global Hlth, Newtown, NSW, Australia Natl Med Sci & Nutr Inst Salvador Zubiran, Mexico City, DF, Mexico
- [6] Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease: A Post Hoc Analysis of DAPA-CKD[J]. ANNALS OF INTERNAL MEDICINE, 2023, 176 (01) : 59 - +论文数: 引用数: h-index:机构:Jongs, Niels论文数: 0 引用数: 0 h-index: 0机构: Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, NetherlandsChertow, Glenn M.论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA Stanford Univ, Sch Med, Dept Epidemiol & Populat Hlth, Stanford, CA 94305 USA Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, NetherlandsMosenzon, Ofri论文数: 0 引用数: 0 h-index: 0机构: Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel Hebrew Univ Jerusalem, Hadassah Med Ctr, Diabet Unit, Dept Endocrinol & Metab, Jerusalem, Israel Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, NetherlandsMcMurray, John J., V论文数: 0 引用数: 0 h-index: 0机构: Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, NetherlandsCorrea-Rotter, Ricardo论文数: 0 引用数: 0 h-index: 0机构: Natl Med Sci & Nutr Inst Salvador Zubiran, Mexico City, DF, Mexico Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, NetherlandsRossing, Peter论文数: 0 引用数: 0 h-index: 0机构: Steno Diabet Ctr Copenhagen, Gentofte, Denmark Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, NetherlandsLangkilde, Anna Maria论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Late Stage Dev Cardiovasc Renal & Metab, BioPharmaceut R&D, Gothenburg, Sweden Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, NetherlandsSjostrom, C. David论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Late Stage Dev Cardiovasc Renal & Metab, BioPharmaceut R&D, Gothenburg, Sweden Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, NetherlandsToto, Robert D.论文数: 0 引用数: 0 h-index: 0机构: UT Southwestern Med Ctr, Dept Internal Med, Dallas, TX USA Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, NetherlandsWheeler, David C.论文数: 0 引用数: 0 h-index: 0机构: UCL, Dept Renal Med, London, England Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, NetherlandsHeerspink, Hiddo J. L.论文数: 0 引用数: 0 h-index: 0机构: Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands George Inst Global Hlth, Sydney, NSW, Australia Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands
- [7] The Effect of Dapagliflozin on Rate of Kidney Function Decline in Patients with CKD: A Prespecified Analysis from the DAPA-CKD Trial[J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 35 - 36Heerspink, Hiddo J. L.论文数: 0 引用数: 0 h-index: 0机构: Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands George Inst Global Hlth, Newtown, NSW, Australia Univ Groningen, Univ Med Ctr Groningen, Groningen, NetherlandsJongs, Niels论文数: 0 引用数: 0 h-index: 0机构: Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands Univ Groningen, Univ Med Ctr Groningen, Groningen, NetherlandsChertow, Glenn M.论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Sch Med, Stanford, CA USA Univ Groningen, Univ Med Ctr Groningen, Groningen, NetherlandsLangkilde, Anna Maria论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Gothenburg, Sweden Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands论文数: 引用数: h-index:机构:Correa-Rotter, Ricardo论文数: 0 引用数: 0 h-index: 0机构: Natl Med Sci & Nutr Inst Salvador Zubiran, Mexico City, DF, Mexico Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands论文数: 引用数: h-index:机构:Sjostrom, David论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Gothenburg, Sweden Univ Groningen, Univ Med Ctr Groningen, Groningen, NetherlandsStefansson, Bergur V.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Gothenburg, Sweden Univ Groningen, Univ Med Ctr Groningen, Groningen, NetherlandsToto, Robert D.论文数: 0 引用数: 0 h-index: 0机构: UT Southwestern Med Ctr, Dallas, TX USA Univ Groningen, Univ Med Ctr Groningen, Groningen, NetherlandsWheeler, David C.论文数: 0 引用数: 0 h-index: 0机构: UCL, London, England Univ Groningen, Univ Med Ctr Groningen, Groningen, NetherlandsGreene, Tom论文数: 0 引用数: 0 h-index: 0机构: Univ Utah Hlth, Salt Lake City, UT USA Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands
- [8] Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD)[J]. JOURNAL OF CARDIAC FAILURE, 2020, 26 (12) : 1111 - 1111McMurray, John J. V.论文数: 0 引用数: 0 h-index: 0机构: Univ Glasgow, Glasgow, Lanark, Scotland Univ Glasgow, Glasgow, Lanark, ScotlandWheeler, David C.论文数: 0 引用数: 0 h-index: 0机构: UCL, London, England Univ Glasgow, Glasgow, Lanark, ScotlandStefansson, Bergur V.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Gothenburg, Sweden Univ Glasgow, Glasgow, Lanark, ScotlandCorrea-Rotter, Ricardo论文数: 0 引用数: 0 h-index: 0机构: Natl Med Sci & Nutr Inst Salvador Zubiran, Mexico City, DF, Mexico Univ Glasgow, Glasgow, Lanark, ScotlandChertow, Glenn M.论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Sch Med, Stanford, CA 94305 USA Univ Glasgow, Glasgow, Lanark, ScotlandGreene, Tom论文数: 0 引用数: 0 h-index: 0机构: Univ Utah, Hlth Sci Ctr Clin & Translat Sci, Salt Lake City, UT USA Univ Glasgow, Glasgow, Lanark, ScotlandHou, Fan Fan论文数: 0 引用数: 0 h-index: 0机构: Southern Med Univ, Guangzhou, Peoples R China Univ Glasgow, Glasgow, Lanark, ScotlandLindberg, Magnus B.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Gothenburg, Sweden Univ Glasgow, Glasgow, Lanark, ScotlandRossing, Peter论文数: 0 引用数: 0 h-index: 0机构: Steno Diabet Ctr, Copenhagen, Denmark Univ Glasgow, Glasgow, Lanark, ScotlandSjostrom, C. David论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Glasgow, Lanark, Scotland Univ Glasgow, Glasgow, Lanark, ScotlandToto, Robert D.论文数: 0 引用数: 0 h-index: 0机构: Ctr Clin & Translat Sci, Dallas, TX USA Univ Glasgow, Glasgow, Lanark, ScotlandLangkilde, Ann Maria论文数: 0 引用数: 0 h-index: 0机构: As, Gothenburg, Sweden Univ Glasgow, Glasgow, Lanark, ScotlandHeerspink, Hiddo J. L.论文数: 0 引用数: 0 h-index: 0机构: Univ Med Ctr Groningen, Groningen, Netherlands Univ Glasgow, Glasgow, Lanark, Scotland
- [9] Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD)[J]. CIRCULATION, 2020, 142 (24) : E482 - E483McMurray, John J.论文数: 0 引用数: 0 h-index: 0机构: Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland Inst Cardiovasc & Med Sci, Glasgow, Lanark, ScotlandWheeler, David C.论文数: 0 引用数: 0 h-index: 0机构: UCL, Dept Renal Med, London, England Inst Cardiovasc & Med Sci, Glasgow, Lanark, ScotlandStefansson, Bergur V.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Biopharmaceut R&D, Late Stage DevCardiovasc Renal & Metab CVRM, Gothenburg, Sweden Inst Cardiovasc & Med Sci, Glasgow, Lanark, ScotlandRotter, Ricardo Correa论文数: 0 引用数: 0 h-index: 0机构: Natl Med Sci & Nutr Inst Salvador Zubiran, Mexico City, DF, Mexico Inst Cardiovasc & Med Sci, Glasgow, Lanark, ScotlandChertow, Glenn M.论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA Stanford Univ, Sch Med, Dept Epidemiol & Populat Hlth, Stanford, CA 94305 USA Inst Cardiovasc & Med Sci, Glasgow, Lanark, ScotlandGreene, Tom论文数: 0 引用数: 0 h-index: 0机构: Univ Utah Hlth Sci, Study Design & Biostat Ctr, Salt Lake City, UT USA Inst Cardiovasc & Med Sci, Glasgow, Lanark, ScotlandHou, Fan Fan论文数: 0 引用数: 0 h-index: 0机构: Nanfang Hosp, Div Nephrol, Guangzhou, Guangdong, Peoples R China Southern Med Univ, Guangzhou, Guangdong, Peoples R China Inst Cardiovasc & Med Sci, Glasgow, Lanark, ScotlandLindberg, Magnus B.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Biopharmaceut R&D, Late Stage Dev Cardiovas Renal & Metab CVRM, Gothenburg, Sweden Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland论文数: 引用数: h-index:机构:Sjostrom, David论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Biopharmaceut R&D, Late Stage DevCardiovasc Renal & Metab CVRM, Gothenburg, Sweden Inst Cardiovasc & Med Sci, Glasgow, Lanark, ScotlandToto, Robert D.论文数: 0 引用数: 0 h-index: 0机构: UT Southwestern Med Ctr, Dept Internal Med, Dallas, TX USA Inst Cardiovasc & Med Sci, Glasgow, Lanark, ScotlandLangkilde, Anna Maria论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Biopharmaceut R&D, Late Stage DevCardiovasc Renal & Metab CVRM, Gothenburg, Sweden Inst Cardiovasc & Med Sci, Glasgow, Lanark, ScotlandHeerspink, Hiddo J. Lambers论文数: 0 引用数: 0 h-index: 0机构: Univ Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland
- [10] Efficacy and Safety of Dapagliflozin by Baseline Glycemic Status: A Prespecified Analysis From the DAPA-CKD Trial[J]. DIABETES CARE, 2021, 44 (08) : 1894 - 1897Persson, Frederik论文数: 0 引用数: 0 h-index: 0机构: Steno Diabet Ctr Copenhagen, Gentofte, Denmark Steno Diabet Ctr Copenhagen, Gentofte, DenmarkRossing, Peter论文数: 0 引用数: 0 h-index: 0机构: Steno Diabet Ctr Copenhagen, Gentofte, Denmark Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark Steno Diabet Ctr Copenhagen, Gentofte, DenmarkVart, Priya论文数: 0 引用数: 0 h-index: 0机构: Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands Steno Diabet Ctr Copenhagen, Gentofte, DenmarkChertow, Glenn M.论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA Stanford Univ, Sch Med, Dept Epidemiol & Populat Hlth, Stanford, CA 94305 USA Steno Diabet Ctr Copenhagen, Gentofte, DenmarkHou, Fan Fan论文数: 0 引用数: 0 h-index: 0机构: Southern Med Univ, Nanfang Hosp, Natl Clin Res Ctr Kidney Dis, Div Nephrol, Guangzhou, Peoples R China Steno Diabet Ctr Copenhagen, Gentofte, DenmarkJongs, Niels论文数: 0 引用数: 0 h-index: 0机构: Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands Steno Diabet Ctr Copenhagen, Gentofte, DenmarkMcMurray, John J., V论文数: 0 引用数: 0 h-index: 0机构: Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland Steno Diabet Ctr Copenhagen, Gentofte, DenmarkCorrea-Rotter, Ricardo论文数: 0 引用数: 0 h-index: 0机构: Natl Med Sci & Nutr Inst Salvador Zubiran, Mexico City, DF, Mexico Steno Diabet Ctr Copenhagen, Gentofte, DenmarkBajaj, Harpreet S.论文数: 0 引用数: 0 h-index: 0机构: LMC Diabet & Endocrinol, Brampton, ON, Canada Steno Diabet Ctr Copenhagen, Gentofte, DenmarkStefansson, Bergur, V论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Biopharmaceut Res & Dev, Gate Stage Dev Cardiovasc Renal & Metab, Gothenburg, Sweden Steno Diabet Ctr Copenhagen, Gentofte, DenmarkToto, Robert D.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX USA Steno Diabet Ctr Copenhagen, Gentofte, DenmarkLangkilde, Anna Maria论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca, Biopharmaceut Res & Dev, Gate Stage Dev Cardiovasc Renal & Metab, Gothenburg, Sweden Steno Diabet Ctr Copenhagen, Gentofte, DenmarkWheeler, David C.论文数: 0 引用数: 0 h-index: 0机构: UCL, Dept Renal Med, London, England George Inst Global Hlth, Sydney, NSW, Australia Steno Diabet Ctr Copenhagen, Gentofte, DenmarkHeerspink, Hiddo J. L.论文数: 0 引用数: 0 h-index: 0机构: Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands George Inst Global Hlth, Sydney, NSW, Australia Steno Diabet Ctr Copenhagen, Gentofte, Denmark